Table 2.
Strain | Antimony Resistance | Drug | Mean IC50 µg/mL (µM) | Promast: Amast Ratio | Cross-Resistance Index (CRI50) (Promast/Amast) |
Selectivity Index (SI50) | |
---|---|---|---|---|---|---|---|
Promastigotes | Amastigotes | ||||||
282/4 | Sb-sensitive | APC12 | ** 0.55 ± 0.02 (1.56 ± 0.06) |
** 0.26 ± 0.01 (0.74 ± 0.03) |
2.09 | NA/NA | 136.08 |
APC14 | ** 0.44 ± 0.07 (1.16 ± 0.18) |
** 0.12 ± 0.02 (0.32 ± 0.05) |
3.64 | NA/NA | 340.75 | ||
APC16 | 0.84 ± 0.05 (2.06 ± 0.12) |
0.31 ± 0.02 (0.76 ± 0.05) |
2.68 | NA/NA | 16.39 | ||
087/11 | Sb-intermediate | APC12 | ** 0.42 ± 0.02 (1.19 ± 0.06) |
** 0.20 ± 0.07 (0.57 ± 0.20) |
2.11 | 0.76/0.77 | 176.90 |
APC14 | ** 0.21 ± 0.00 (0.55 ± 0.00) |
** 0.19 ± 0.01 (0.50 ± 0.03) |
1.05 | 0.48/1.58 | 215.21 | ||
APC16 | 1.49 ± 0.6 (3.66 ± 1.47) |
0.29 ± 0.01 (0.71 ± 0.02) |
5.15 | 1.77/1.76 | 17.52 | ||
275/18 | Sb-resistant | APC12 | ** 0.49 ± 0.03 (1.39 ± 0.09) |
** 0.23 ± 0.01 (0.65 ± 0.03) |
2.10 | 0.89/0.88 | 153.83 |
APC14 | ** 0.37 ± 0.05 (0.97 ± 0.13) |
** 0.28 ± 0.00 (0.74 ± 0.00) |
1.31 | 0.84/2.33 | 146.04 | ||
APC16 | 1.26 ± 0.06 (3.09 ± 0.15) |
0.51 ± 0.00 (1.25 ± 0.00) |
2.49 | 1.50/1.65 | 9.96 |
* p < 0.05, ** p < 0.01 compared to APC16. NA Data not available.